Strategic Partnerships Inbiomotion's recent collaboration with Palex Medical SA and distribution partnerships in Spain and Portugal position it as a key player expanding its market reach in Europe. This creates opportunities for sales teams to offer complementary diagnostic tools or healthcare solutions aligned with their local distribution channels.

Innovation in Oncology With its proprietary MAFTest for breast cancer and focus on personalized medicine, Inbiomotion targets a niche segment of oncology diagnostics. There is potential to develop or sell additional precision medicine tools, laboratory services, or clinical integration solutions tailored to early-stage breast cancer treatment providers.

Research & Development Focus The company's involvement in multi-phase clinical analyses and long-term follow-up studies demonstrate ongoing R&D activity. This opens opportunities to supply advanced biomarker development tools, research reagents, or collaborate on future clinical trials for new cancer diagnostics.

Market Niche Leadership Inbiomotion’s focus on single-gene biomarkers for bone metastasis and recent clinical validations position it as a leader in niche cancer diagnostics. This provides potential sales avenues in specialized laboratory equipment, digital health integrations, or specialized reagent kits tailored for precision oncology labs.